APAMIT

Asia-Pacific Acute Myocardial Infarction Trial. A trial comparing safety and efficacy of combined tPA and abciximab therapy and rescue angioplasty versus abciximab and primary angioplasty for AMI.
Conclusion Abciximab + low dose tPA was effective in achieving TIMI 3 grade flow; primary angioplasty with stent + abciximab restored normal coronary flow.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.